Complex Arterial and Venous Thrombosis in Polycythemia Vera: what Does Leukocytosis Predict?

Denny Suwanto, Muhammad Aminuddin, Eka Prasetya Budi Mulia

Research output: Contribution to journalArticlepeer-review

Abstract

Thromboembolic events represent the main cause of morbidity and mortality in patients with polycythemia vera. Leukocytosis has been identified as an important risk factor for development of vascular thrombosis. A 47-year-old woman with polycythemia vera presented with pain and swelling in her right calf. She was scheduled to receive anagrelide which was effective on polycythemia and thrombocytosis, but leukocytosis persisted. She was diagnosed with thrombosis in right popliteal vein and left common femoral vein by duplex ultrasonography. We suggested a role for leukocytosis in inducing thrombotic phenomenon in our patient with polycythemia vera.

Original languageEnglish
Pages (from-to)33-36
Number of pages4
JournalIranian Journal of Blood and Cancer
Volume14
Issue number1
Publication statusPublished - 2022
Externally publishedYes

Keywords

  • Leukocytosis
  • Polycythemia vera
  • Thrombocytosis
  • Thrombotic event
  • Treatment

Fingerprint

Dive into the research topics of 'Complex Arterial and Venous Thrombosis in Polycythemia Vera: what Does Leukocytosis Predict?'. Together they form a unique fingerprint.

Cite this